Back by popular demand! After receiving a great deal of positive feedback from conference attendees over the last two years, we will be offering another set exciting Round Room Discussion topics at the annual conference. No matter your discipline or background, you will be able to choose from the following relevant and engaging topics:
1. Helping people with SCI navigate clinical trials: from acute care to living in the community.
a. Are there key inclusion and exclusion criteria for each trial? Who do you choose and who do you deny for each trial?
b. Does it matter what age the patient is? Too young or too old?
c. Does it matter what co-morbidities the patient has? Overall health? Psychiatric issues? Financial status?
d. Could discuss the psychological benefits and costs to each approach; the financial/insurance implications of each; etc.
e. How do we envision patients participating in different trials over the course of their injury, specifically which ones might
preclude participation in other ones?
f. How do we distinguish experimental care from clinical trial?
2. Opportunities and obstacles in developing and maintaining a career in the field of spinal cord injury
a. This discussion will be made relevant to all of its audience members including those who recently joined the field and those who are seasoned; those who are clinicians and those who conduct research; those who work with youth and those who work with geriatric patients; those who work with veterans and those who work with civilians; and those who work in/with Foundations and other funders (Nielson, NIH, etc…)
b. Consider the pros and cons of working in academic vs. clinical settings and private vs. public settings.
c. How has the insurance industry affected our ability to work effectively with individuals with SCI/D? and how does that affect how we feel as
clinicians? Does this contribute to professional burnout?
d. How does the increased difficulty in finding funding for research affect the field of SCI? For the researchers, the clinicians, and for the patients?
e. What does the future hold? In what direction are we headed?
3. Traumatic and Non-Traumatic Myelopathy: When are they the same and when are they different?
a. This discussion will bring in all clinical disciplines and researchers. It will provide those who attended the pre-course and
those who did not with the opportunity to discuss this topic in great depth and to learn from each other.
b. What are the psychological implications of non-traumatic vs. traumatic etiology on the patient and his/her family members??
c. What are the different therapy approaches, medical restrictions, and pharmacological implications?
d. Should the model systems collect data only on individuals with SCI that are traumatic in nature?
e. Is there an additional stimulus question that could bring in the bench science people?
f. Is the distinction of etiology being addressed well in pre-clinical models?